Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea

• Published in: Journal of Korean medical science Vol. 35; no. 23; pp. e223 - 12
• Main Authors: Lee, Ji Yeon, Kim, Hyun Ah, Huh, Kyungmin, Hyun, Miri, Rhee, Ji-Young, Jang, Sukbin, Kim, Ji-Yeon, Peck, Kyong Ran, Chang, Hyun-Ha
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Academy of Medical Sciences 15.06.2020; 대한의학회
• Subjects: Age Factors; Aged; Aged, 80 and over; Betacoronavirus; C-Reactive Protein - analysis; Coronavirus Infections - mortality; Coronavirus Infections - pathology; COVID-19; Female; Hospitalization; Humans; Hypoxia - pathology; Intensive Care Units; Male; Original; Pandemics; Pneumonia, Viral - mortality; Pneumonia, Viral - pathology; Republic of Korea; Respiration, Artificial - statistics & numerical data; Respiratory Insufficiency - mortality; Retrospective Studies; Risk Factors; SARS-CoV-2; Treatment Outcome; Ventilators, Mechanical - statistics & numerical data; 의학일반; Republic of Korea; COVID-19; Elderly; Outcome; Risk Factors
• ISSN: 1011-8934; 1598-6357; 1598-6357
• DOI: 10.3346/jkms.2020.35.e223

The mortality risk of coronavirus disease 2019 (COVID-19) is higher in patients with older age, and many elderly patients are reported to require advanced respiratory support. We reviewed medical records of 98 patients aged ≥ 65 years who were hospitalized with COVID-19 during a regional outbreak in Daegu/Gyeongsangbuk-do province of Korea. The outcome measures were in-hospital mortality and the treatment with mechanical ventilation (MV) or high-flow nasal cannula (HFNC). The median age of the patients was 72 years; 55.1% were female. Most (74.5%) had at least one underlying condition. Overall case fatality rate (CFR) was 20.4%, and median time to death after admission was 8 days. The CFR was 6.1% among patients aged 65-69 years, 22.7% among those aged 70-79 years, and 38.1% among those aged ≥ 80 years. The CFR among patients who required MV was 43.8%, and the proportion of patients received MV/HFNC was 28.6%. Nosocomial acquisition, diabetes, chronic lung diseases, and chronic neurologic diseases were significant risk factors for both death and MV/HFNC. Hypotension, hypoxia, and altered mental status on admission were also associated with poor outcome. CRP > 8.0 mg/dL was strongly associated with MV/HFNC (odds ratio, 26.31; 95% confidence interval, 7.78-88.92; < 0.001), and showed better diagnostic characteristics compared to commonly used clinical scores. Patients aged ≥ 80 years had a high risk of requiring MV/HFNC, and mortality among those severe patients was very high. Severe initial presentation and laboratory abnormalities, especially high CRP, were identified as risk factors for mortality and severe hospital course.